Your browser doesn't support javascript.
loading
Atorvastatin added to interferon beta for relapsing multiple sclerosis: 12-month treatment extension of the randomized multicenter SWABIMS trial.
Kamm, Christian P; El-Koussy, Marwan; Humpert, Sebastian; Findling, Oliver; Burren, Yuliya; Schwegler, Guido; Donati, Filippo; Müller, Martin; Müller, Felix; Slotboom, Johannes; Kappos, Ludwig; Naegelin, Yvonne; Mattle, Heinrich P.
Afiliación
  • Kamm CP; Department of Neurology, Inselspital, University Hospital Bern and University of Bern, Bern, Switzerland.
  • El-Koussy M; Department of Diagnostic and Interventional Neuroradiology, Inselspital, University Hospital Bern and University of Bern, Bern, Switzerland.
  • Humpert S; Department of Neurology, Inselspital, University Hospital Bern and University of Bern, Bern, Switzerland.
  • Findling O; Department of Neurology, Inselspital, University Hospital Bern and University of Bern, Bern, Switzerland.
  • Burren Y; Department of Diagnostic and Interventional Neuroradiology, Inselspital, University Hospital Bern and University of Bern, Bern, Switzerland.
  • Schwegler G; Department of Neurology, Cantonal Hospital Aarau, Aarau, Switzerland.
  • Donati F; Department of Neurology, Spitalzentrum Biel, Biel, Switzerland.
  • Müller M; Department of Neurology, Cantonal Hospital Lucerne, Luzern, Switzerland.
  • Müller F; Department of Neurology, Cantonal Hospital, Muensterlingen, Muensterlingen, Switzerland.
  • Slotboom J; Department of Diagnostic and Interventional Neuroradiology, Inselspital, University Hospital Bern and University of Bern, Bern, Switzerland.
  • Kappos L; Department of Neurology, University Hospital, University of Basel, Basel, Switzerland.
  • Naegelin Y; Department of Neurology, University Hospital, University of Basel, Basel, Switzerland.
  • Mattle HP; Department of Neurology, Inselspital, University Hospital Bern and University of Bern, Bern, Switzerland.
PLoS One ; 9(1): e86663, 2014.
Article en En | MEDLINE | ID: mdl-24497963

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Pirroles / Adyuvantes Inmunológicos / Interferón beta / Esclerosis Múltiple Recurrente-Remitente / Ácidos Heptanoicos Tipo de estudio: Clinical_trials Idioma: En Revista: PLoS One Año: 2014 Tipo del documento: Article País de afiliación: Suiza

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Pirroles / Adyuvantes Inmunológicos / Interferón beta / Esclerosis Múltiple Recurrente-Remitente / Ácidos Heptanoicos Tipo de estudio: Clinical_trials Idioma: En Revista: PLoS One Año: 2014 Tipo del documento: Article País de afiliación: Suiza